ROXRO PHARMA, Inc. develops drugs for pain treatment. Its products include ROX-888, an intranasal formulation for the treatment of dental and postoperative pain; and ROX-828, a non-opioid and non-triptan intranasal product for the treatment of migraine. ROXRO PHARMA, Inc. was founded in 1999 and is based in Menlo Park, California.
Crunchbase Investment Rounds
|Date||Amount||Round||Valuation||Lead Investor||Other Investors|
|2007-06-12||$42,700,000||Series B||Sutter Hill Ventures, Prospect Venture Partners||Thomas Weisel Partners|
|2005-10-19||$21,600,000||Series B||Sutter Hill Ventures, Prospect Venture Partners|